• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA CH CREATININE_2; CREATININE_2 (CREA_2)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA CH CREATININE_2; CREATININE_2 (CREA_2) Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/26/2024
Event Type  malfunction  
Event Description
A falsely depressed creatinine_2 (crea_2) patient sample result was obtained on an atellica ® ch 930 analyzer compared to repeat testing.The falsely depressed patient result was reported to the physician and questioned.The same sample was reprocessed on the same atellica ® ch 930 analyzer.On 27-feb-2024 the same sample was reprocessed on an alternate atellica ® ch 930 analyzer and resulted higher.The higher results were considered correct and reported to the physician.There are no known reports of patient intervention or adverse health consequences due to the falsely depressed creatinine_2 (crea_2) result.
 
Manufacturer Narrative
An outside united states (ous) customer contacted the siemens healthcare diagnostics remote services center (rsc) regarding a falsely depressed creatinine_2 (crea_2) result obtained on an atellica ® ch 930 analyzer.Siemens is investigating the event.
 
Manufacturer Narrative
Additional information (15-march-2024): siemens healthcare diagnostics headquarters support center (hsc) concluded the investigation of the event.Hsc reviewed the information provided by the customer.Quality control recovered within the customer's acceptable ranges.Siemens service performed standard troubleshooting actions and confirmed the system met specifications.The cause of the event is unknown.A potential product issue was not identified.The customer is operational.The device is performing within specifications.No further evaluation is required.Section h6 has been updated to reflect the hsc investigation.Initial mdr 2432235-2024-00048 was filed on 11-march-2024.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA CH CREATININE_2
Type of Device
CREATININE_2 (CREA_2)
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict ave
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
500 gbc drive
po box 6101
newark DE 19714 6101
Manufacturer Contact
linda barletta
500 gbc drive
po box 6101
newark, DE 19714-6101
MDR Report Key18875044
MDR Text Key337327932
Report Number2432235-2024-00048
Device Sequence Number1
Product Code CGX
UDI-Device Identifier00630414596457
UDI-Public00630414596457
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K161494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number11097596
Device Lot Number232081
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/28/2024
Initial Date FDA Received03/11/2024
Supplement Dates Manufacturer Received03/15/2024
Supplement Dates FDA Received03/22/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-